Most potential oncology drugs fail during the drug development pipeline, even when there has been promising data for their efficacy during the in vitro stage. This makes it vital to identify in vitro ...

Research and drug discovery are undergoing a transformation, driven by the rise of 3D cell culture models that better replicate human biology. Unlike traditional 2D cultures and animal models, which ...

This breakthrough combines 3D bioprinting, organoid technology, and placental research. It may pave the way for safer drugs, ...

Organoids have emerged as a groundbreaking technology in cell biology, offering a three-dimensional culture system that ...

By 3D bioprinting miniature placentas, scientists have provided a new way to study complications in pregnancy, with the ...

The placenta is a unique organ that exists only during pregnancy, growing at tumour-like speed to the size of a small dinner ...

A recent study from the School of Engineering & Applied Science took a key step in breaking down the complex, and often misunderstood, patterns behind how cells move through the body. Published in the ...

Spheroids Market revenue is expected to grow at a CAGR of 23.3% from 2025 to 2032, reaching nearly USD 4183.33 Mn by 2032. Spheroids are no longer just lab models, they’re catalysts accelerating drug ...

The new model mimics the structure and function of the human conjunctiva in a lab dish, even producing its own tears. When you purchase through links on our site, we may earn an affiliate commission.

Engineered 3D skin model successfully simulates early wound healing, offering insights into inflammatory responses and potential therapeutic applications.